Priority Date: 10.04.12 (US 201213443023)

METHOD OF USING NUTRITIONAL COMPOUNDS DIHYDROQUERCETIN (TAXIFOLIN) AND ARABINOGALACTAN IN COMBINATION WITH DIHYDROQUERCETIN (TAXIFOLIN) TO REDUCE AND CONTROL CARDIOMETABOLIC RISK FACTORS ASSOCIATED WITH METABOLIC SYNDROME AND HYPERCHOLESTEROLEMIA

  • Application ID: EP12874065
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

operating since 1995
1325.42
Headquarter in Leeds and 20 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC combination A23 (FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES) and A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). We found, that Engel Patentanwaltskanzlei, Vereenigde Octrooibureaux NV (V.O.), Dennemeyer SA, ip21 Ltd, Plougmann & Vingtoft A/S and 64 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 10.04.2012 - Priority Date (US 201213443023)
  • 17.10.2013 - Publication A1 (WO2013154516)
  • 24.12.2014 - Publication A2 (EP2814336)